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The Mid-Atlantic Ethics Committee
Newsletter is a publication of the
Maryland Health Care Ethics
Committee Network, an initiative of
the University of Maryland Francis
King Carey School of Law’s Law &
Health Care Program. The Newsletter
combines educational articles with
timely information about bioethics
activities. Each issue includes a feature
article, a Calendar of upcoming
events, and a case presentation and
commentary by local experts in
bioethics, law, medicine, nursing, or
related disciplines.

For better and worse, social media has become an essential part of our lives.
According to the Pew Research Center, nearly 70% of Americans use some type
of social media with Facebook and YouTube being among the most popular
platforms.1
As social media use has become more widespread, it has presented healthcare
providers, institutions and patients with unique opportunities for connection.
For providers, online platforms can facilitate continuing education, disseminate
research ﬁndings, foster connections with experts and allow clinicians to solicit
advice from colleagues regarding patient issues. In addition, these networks
can provide critical peer support for clinicians by providing a forum “to
share workplace experiences, particularly those events that are challenging
or emotionally charged.”2 The appeal of these networks is evidenced by their
growing membership rosters. According to Doximity, one of the leading online
clinician networks, more than 70% of U.S. doctors are members, with more
physician members than the American Medical Association. 3
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Social networking sites
for clinicians
• Doctorshangout.com
• Sermo.com
• Doximity.com
• Figure1.com
• WeMedup.com
• MomMD.com
• AllNurses.com

connection with photos of her
genitals taken by a nurse while she
was undergoing surgery and later
shared with co-workers.6
These incidents concern us not
only as individuals and patients
but also as members of heatlh care
ethics committees. They also raise
important ethical concerns related
to conﬁdentiality, informed consent,
and professionalism.7

At the organizational level, social
media can be a highly eﬀective
mechanism for enhancing a
health care entity’s visibility and
developing relationships with
surrounding communities. Many
hospitals and medical centers now
have Facebook pages and Twitter
accounts as well as YouTube
channels. For patients, social
media platforms have enabled
improved communication with
providers, strengthened patient
involvement in care, and fostered
online communities of patients,
such as PatientsLikeMe, that allow
for information sharing and social
support.

Problems arise, in part, because of
the conﬂict between the prevailing
norms of health care settings and
those for social media platforms.8
In the health care context, laws and
codes of conduct emphasize privacy,
conﬁdentiality, and professionalism.
In contrast, in the social media
realm, there are no such formal
strictures and the prevailing values
emphasize sharing, transparency
and informality. It has become
increasingly clear that health care
providers and facilities must take a
proactive approach to address the
use of social media in the health
care context or risk becoming the
headline.

Despite these beneﬁts, there are
also signiﬁcant risks associated
with the use of social media in the
healthcare context. We have all
seen the headlines – an employee
at a health care entity photographs
a patient in a vulnerable moment
and shares the photos with friends
via social media applications
such as SnapChat or Facebook. A
ProPublica analysis, updated in June
2017, identiﬁed 65 instances since
2012 where inappropriate patient
images were posted to social media
by employees of long-term care
facilities.4 This past September, two
employees from a naval hospital
were removed from patient care
roles after posting a video where
they mishandled an infant and
referred to babies as “mini-Satans.”5
In December, a woman ﬁled suit
against her hospital employer in

Legal Considerations
Apart from the negative publicity,
misuse of social media can have
serious legal ramiﬁcations for health
care providers and institutions.
HIPAA, the federal Health Insurance
Portability and Accountability Act,
sets standards for the disclosure
and use of individually identiﬁable
health information (IIHI). IIHI
includes any information that relates
to the past, present or future physical
or mental health of an individual
or provides enough information
that leads someone to believe that
the information could be used to
identify an individual (e.g. date
of birth, social security number,
etc.).
Under HIPAA, a covered entity
such as a health care provider or
facility may not use or disclose
protected health information unless

such disclosure is expressly
permitted under the HIPAA
regulations (e.g. for treatment,
payment for services rendered,
quality assessment/improvement)
or the individual patient or their
representative authorizes the
disclosure in writing. Although
HIPAA does not speciﬁcally
reference social media, the HIPAA
Privacy Rule prohibits unauthorized
disclosure of IIHI in “electronic”
form. In order to share patient
information on a social media
platform in a HIPAA-compliant
manner, the patient must provide
written consent or the information
must be de-identiﬁed to prevent any
reader from identifying the patient.
Consider the following case:
Jamie, a nurse, has been working
in hospice care for the last six years
and one of her patients, Maria,
maintained a hospital-sponsored
communication page to keep
friends and family updated on her
battle with cancer. One day, Maria
posted about her depression. As
her nurse, Jamie wanted to provide
support, so she posted, “I know
the last week has been diﬃcult.
Hopefully the new happy pill will
help, along with the increased dose
of morphine. I will see you on
Wednesday.” The site automatically
listed the user’s name with each
comment. The next day, Jamie was
shopping at the local grocery store
when a friend stopped her to ask
about Maria’s condition. “I saw
your post yesterday. I didn’t know
you were taking care of Maria,”
the friend said. “I hope that new
medication helps with her pain.”
While the nurse’s actions are well
intended, her post constitutes a
breach of conﬁdentiality and a
HIPAA violation that puts the
hospital at risk for ﬁnes and other
penalties.

Professional Standards
Recognizing the risks presented
by clinician use of social media,
several professional organizations
have issued guidelines regarding its
ethical use. The American Medical
Association (AMA), the American
Nurses Association (ANA), the
National Council of State Boards
of Nursing (NCSBN), among
others, have issued guidance to help
providers navigate social media
while maintaining protections for
patient privacy and conﬁdentiality.
Results of a 2010 survey of state
medical boards illustrate the need
for these professional standards.
According to the survey, more
than 90 percent of medical boards
received reports of violations of
online professionalism. These
violations include inappropriate
contact with patients via the
internet, inappropriate prescribing,
and misrepresentation of credentials
or clinical outcomes. Both the
Maryland Board of Physicians and
Board of Nursing have disciplined
licensees for unprofessional
behavior involving misuse of social
media.
Professional Standards
With slight variation, the various
professional standards emphasize
the following:
1. Clinician responsibility to
maintain legal and ethical standards
of privacy and conﬁdentiality
2. Prohibitions against posting
identifying information about
patients online
3. Vigilance regarding online
privacy settings and safeguarding
patient information
4. Distinct boundaries between
personal and professional online
presence
5. Consistent, appropriate standards
for patient-provider interactions
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Ethical Considerations
In addition to the legal implications,
there are important ethical
considerations about use of social
media. Issues of conﬁdentiality,
a core ethical principle for health
care providers dating back to the
Hippocratic Oath, patient privacy,
informed consent, professionalism
and trust should all be given careful
consideration in any interactions or
activities involving social media.8
As the NCSBN notes, many
times inappropriate disclosure of
patient information is unintentional
and may be the result of a lack
of understanding on the part of
providers. For example, clinicians
may mistakenly believe that their
communication or post is private. As
the American Medical Association
notes, “privacy settings are not
absolute…once on the Internet,
content is likely there permanently.”9
Providers are likely to encounter
various ethical challenges as they
navigate social media in the care
context.
“Friending” a patient
The American College of
Physicians discourages physicians
from accepting “friend” requests from
patients and recommends limiting
online interactions to discussions
involving the patient’s care in the
context of secure, approved electronic
media such as MyChart. The
NCBSN also urges caution for nurses
regarding online interactions with
patients and recommends consultation
with employer policies for guidance.
Employing social media and search
engines during course of treatment
While the appropriate response to
“friend” requests might seem clearcut, there may be less clarity when
it comes to health care provider use
of sites like Facebook or Google to
glean additional information about
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patients. Professional organizations
have not taken a strong position
against so-called “patient-targeted
Googling,” in part because it
may be necessary under certain
circumstances, such as attempts to
identify unconscious patients.10
Guidelines from the American
College of Physicians and the
Federation of State Medical Boards,
however, advise caution in the use of
online sources to obtain information
about patients, warning of the risk
that such use may veer into “curiosity,
voyeurism, and habit” and blur
personal and professional boundaries.
Such “digital tracking” may also
undermine the trust a patient has for
their provider if the patient discovers
that a physician has engaged in these
types of searches.
Visitors posting pictures of patients
or identifying information
As cell phones have proliferated,
so has the tendency to document
moments and events with their
built in cameras. Although a visitor
wanting to take a picture of a friend
or family member’s new baby is
understandable, such photos may
be problematic if they include other
patients in the background. While
visitors are not considered “covered
entities” in terms of HIPAA, many
institutions have instituted policies
regarding cell phone use in order
to meet their ethical obligations
to protect patient privacy and
conﬁdentiality. Stanford Hospital’s
policy, for example, prohibits visitors
and patients from photographing
other patients, visitors, staﬀ or
physicians without permission.
The hospital reserves the right
to remove or destroy any photo
taken in violation of the policy and
requires consultation with hospital
security and risk management if an
individual refuses to comply. Even
when a policy is in place, however,
enforcement remains a challenge.

Implications for Ethics Committees
In many of the cases involving
healthcare provider use of social
media, the behavior at issue falls
squarely into the category of
unethical, inappropriate and, in
some cases, illegal engagement
with social media. There are many
cases, however, where a deﬁnitive
determination is much more
challenging. Such cases present an
opportunity for health care ethics
committees to provide guidance.
Ethics committees might consider
leading eﬀorts to develop social
media policies and guidelines for
health care institutions that have yet
to adopt formal policies. Policies
governing provider and employee
use can emphasize the ethical
obligations to patients, clearly outline
prohibited behaviors regarding use
of patient information on social
media, and incorporate key input
from stakeholders such as legal
counsel and information technology
personnel.
For institutions that have initiated
the process or implemented policies,
the ethics committee may have a role
in the periodic review of the policy
to ensure that it is comprehensive
and up-to-date. There is also the
potential for ethics committees to
take an active role in the review
and adjudication of cases involving
potential violations of social media
policy. Ethics committees might also
facilitate training activities following
adoption of a social media policy,
working with providers and other
health care entity staﬀ to review and
implement standards.
Diane Hoﬀmann, JD, MS
Professor & Director
Law & Health Care Program
University of Maryland
Carey School of Law
Lauren Levy, JD, MPH
Managing Director
Law & Health Care Program
University of Maryland
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IS IT EVER OK FOR CLINICIANS TO GOOGLE THEIR PATIENTS?
This is a question that has
been posed as an ethical issue
for some physicians. In the
publication Psychiatric News, a
psychiatrist wrote in:
“We have learned that our
psychiatry residents routinely
Google their patients. On one
recent occasion, the resident
discovered that an inpatient was
on a most-wanted list in another
state for arson despite having
denied a history of illegal
behavior. Is it ethical to do a
Google search on your patient’s
name?”
APA’s Oﬃce of Ethics
responded that “Googling” a

patient is not necessarily unethical
but “it should be done only in the
interests of promoting the patient’s
care and well-being and never to
satisfy the curiosity or other needs
of the psychiatrist. Also important
to consider is how such information
will inﬂuence treatment and how
the clinician will ultimately use the
information.”

The APA ethicist goes on to say
that, “The standard of practice for
learning about a patient’s medical
condition is through face to face
interviews and this information
may be supplemented by collateral
information, for example, medical
records or family members.
Refusal or inability by patients
to provide important historical
information is not uncommon; in
this circumstance, collateral data
may assume an important role.”
Zilber (2014), cited above.
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INTEPROFESSIONAL, INTERFAITH ETHICS
FORUM ON SUBSTANCE USE DISORDERS
On November 7, 2017, MHECN partnered with the University of Maryland Schools of Law, Medicine, Nursing,
Pharmacy, and Social Work, the UMB Graduate School, and the Institute for Jewish Continuity to present the 4th annual
interprofessional forum on ethics and religion in health care. Prior topics have included end-of-life care, aging, and
organ donation and transplantation. This fourth forum explored the topic of substance use disorders (SUDs). To view
archival presentations, visit: http://www.nursing.umaryland.edu/academics/pe/events/interprofessional-forum-on-ethicsand-religion-in-healthcare/
TRANSTHEORETICAL MODEL OF INTENTIONAL BEHAVIOR CHANGE
In the opening plenary session, Dr. Carlo DiClemente, PhD, recounted a story from a New York Times article about
a woman who was having dinner with a friend. When asked if she would like wine with dinner, the woman responded,
“Not for me … I’m celebrating 10 years of sobriety this weekend.” At the end of the meal, to her amazement, the wait
staﬀ came to her table with a dish of ice cream garnished with a burning candle, singing “Happy Birthday” to recognize
her recovery accomplishment. While this story signals progress in eﬀorts to de-stigmatize drug addiction, there are many
other stories of individuals with substance use disorders (SUDs) who routinely face others’ scorn, blame, and intolerance.
DiClemente, a Professor of Psychology at the University of Maryland Baltimore County, is known for his work
developing and applying the Transtheoretical Model of Intentional Behavior Change to those with SUDs. This model
describes stages of change both into addictive behavior (e.g., regular use of and dependence on a drug in harmful ways)
and into recovery from that addiction. Moving through the stages (Precontemplation, Contemplation, Preparation, Action,
and Maintenance) takes time, is not linear, and is inﬂuenced by various risk and protective factors, such as shared beliefs
(e.g., “drinking alcohol is cool” or “using heroin is OK as long as you don’t shoot it into your veins”). Many people take
opioids to manage pain and do not become addicted. Addiction in SUD involves both drug dependence (when the body
gets used to a drug such that suddenly stopping it will cause physical symptoms of withdrawal) and abuse. A person in
this maintenance stage of addiction is in precontemplation for addictions recovery. As with the journey through the stages
of addiction, moving through the stages of addictions recovery takes time, is not linear, and is inﬂuenced by a host of
factors that inﬂuence whether an individual will overcome the barriers to behavior change.
Examples of the many barriers individuals with SUDs face include neurobiological adaptation (i.e., the brain adapts
to frequent exposure to the addictive substance, which can sometimes cause permanent brain damage), the tendency
to associate with others with SUDs, and loss of social supports from immoral or illegal behaviors aligned with ﬁnding
more drug to avoid the emotional and physical pain of withdrawal. Thus, while individuals may start using a substance
to experience pleasure, they keep using it to avoid pain. This impairs self-regulation and increases impulsivity, making it
even more diﬃcult to exercise the control needed to stop using. As the addicted individual’s world narrows, maintaining
the drug use becomes more highly valued and meaningful and takes over the person’s life.
Telling someone to “just stop using” is meaningless without walking them through the stages of change and providing
appropriate supports along the way. DiClemente likens helping someone through the steps of recovery to a parent holding
the hands of a toddler just learning to walk. He urges health care providers to appropriately evaluate SUD severity and
treat the whole person, rather than SUD in isolation. For example, a person with SUD who also has attention deﬁcit
hyperactivity disorder (ADHD) has a higher risk of relapse due to even further reduced self-regulation (i.e., a weakened
“self-control muscle”). Accordingly, rehabilitation from severe SUD often takes many months, as individuals need to
build self-control and conﬁdence. This comes from small steps, like making a bed or cleaning up after a meal.
Re-integration into society requires systems level changes. Putting someone into a three week recovery program and
sending them back to the same environment and expecting them to resist the temptation to use again is not a formula
for success. Research shows that one year after being diagnosed with diabetes, only about 20% of patients adhere to the
prescribed diet and lifestyle recommendations they were given. Just as we continue working with these patients to help
them manage their disease, we owe the same to persons with SUDs. Successful recovery occurs over a long period of
time, involves multiple interventions, and requires an integrated, interprofessional, collaborative approach that treats the
whole person rather than a disease.
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Addictions Medicine Specialists
Christopher Welsh, MD,
Associate Professor in the
Department of Psychiatry at the
University of Maryland School of
Medicine and an addictions treatment
specialist reviewed the milestones
leading up to the current opioid
overdose epidemic, including a
focus on undertreatment of pain and
pharmaceutical industry lobbying
and marketing eﬀorts accounting
for a dramatic increase in opioid
prescribing in the 1990s and 2000s.
(New prescribing guidelines hope to
thwart inappropriate over-prescribing,
such as the Centers for Disease
Control’s guidelines at https://www.
cdc.gov/drugoverdose/prescribing/
guideline.html.) Some of the many
who received such prescriptions
were predisposed toward addiction
based on their genetics (accounting
for about 60% of drug addictions)
and life circumstances (e.g., poor
and unemployed persons, or victims
of prison system injustice). The
trend of purchasing opioids online
is partly to blame for the increased
fatal overdoses, as these are much
more potent formulations. Some
small towns are spending the majority
of their public health budgets on
providing opioid antagonists like
naloxone to prevent overdose deaths,
with little left to spend on eﬀective
addictions prevention and treatment
programs.
Perspectives from the lens of
religion and spirituality
Rabbi Shmuel Silber, the founder
and Dean of the Institute for Jewish
Continuity and Rabbi at Suburban
Orthodox Congregation Toras
Chaim in Baltimore, Maryland,
shared insights from the Jewish faith
tradition. In Judaism, people are
considered inherently good, even
when they behave badly. To address
SUD, the source of a person’s pain
would be explored. Often there is

prior trauma that requires healing
or acknowledgment. Sometimes, a
person traces his substance addiction
to a feeling that his life is not going
the way he expected; he is not
happy and turns to substance use
to change that. This might stem
from a belief that one has a right to
always be happy and content. Yet,
true happiness can’t come from
something you pop into your mouth
or veins; it is a byproduct of eﬀorts
and accomplishments that bring
meaning to one’s life. Religious
leaders must educate those looking
to them for support that despite
there being valid reasons for some
to succumb to substance addiction,
individuals must own their own
circumstance, rather than giving away
power by seeing themselves only as
victims. “If we want people to heal,”
Rabbi Silber implored, “we must
empower them with the realization
that change is possible, and that it’s
okay to fail” (quoting Proverbs 24:16,
“for though the righteous fall seven
times, they rise again”). In Judaism,
righteousness is not in avoiding
failure, but being willing to learn and
grow from it, and get back up again.
Rabbi Silber encouraged an approach
of accepting and loving people as
they are while believing in their
capacity to change and grow, and
not reducing a person to his or her
addiction or destructive behavior.
Rev. Milton Emanuel Williams,
Jr., the founder and pastor of New
Life Evangelical Baptist Church in
East Baltimore and President of the
Turning Point Methadone Treatment
Clinic, gave a moving address
about his own experiences serving
individuals seeking recovery from
addiction. The Turning Point clinic
is one of the ﬁrst faith-based, and the
nation’s largest, methadone treatment
center. Rev. Williams has lost
friends and church members over his
decision to provide SUD treatment
within the walls of his church. His
life has been threatened by drug

dealers who view him as a threat to
their revenue stream. He doesn’t care.
As he watches individuals moving
through the stages of addictions
recovery, he sees whole family units
being reassembled. Rebuilding the
family is at the root of addressing
SUD at its core. This starts with a
message of love: God’s love for each
person. Whether one is religious or
spiritual, one can start from this place
of loving another and oﬀering hope
for change.
Kathi Storey, MA, a chaplain at
the University of Maryland Medical
Center, reiterated the message of
dwelling from a place of love and
forgiveness through spirituality.
Spirituality is the belief in something
greater than oneself. It gives a person
strength in diﬃcult situations. It gives
life meaning. For some people, there
is great overlap in their spirituality,
religion, and morality. But just
because someone is not religious
or doesn’t believe in God doesn’t
mean the person is not spiritual.
Non-religious individuals active in
traditional 12-step recovery programs
may interpret “God” and “prayer” in
non-religious ways (although courts
have deemed such programs to be
“religious” and thus unconstitutional
for judges to mandate). Chaplain
Storey’s experiences ministering
to patients and families challenged
by drug addiction have taught her
that religion can both nurture and
thwart the spiritual transcendence
necessary to overcome addiction.
She recalled one patient whose wife
insisted that her husband simply go
to church and “stay clean” rather than
get help outside of the church for
his alcoholism. However, Storey’s
own husband enjoyed 14 years
of continuous sobriety before he
died, largely due to support from
Alcoholics Anonymous, his church,
and his employer. The common
thread throughout Rev. Milton’s,
Rabbi Silber’s, and Chaplain Storey’s
remarks was that healing from
Mid-Atlantic Ethics Committee Newsletter 7

addiction requires love and support
from multiple sources, and that hope
for positive change lies in community
and the power of faith.
Multiple perspectives on ethics and
SUDs
A panel addressed interprofessional
perspectives on ethical issues arising
in addressing SUDs, including
analysis of a case study. Sorting
through the ethical issues involves
weighing harms and beneﬁts
and identifying what comprises
“fairness.”
Pharmacist’s perspective
Bethany Dipaula, PharmD,
psychiatric pharmacist and director
of the University of Maryland
Psychiatric Pharmacy Residency
Program, reviewed medicationassisted treatment (MAT) options
for patients with opioid addiction
(naltrexone, buprenorphine, and
methadone). There are three
medications approved to treat alcohol
addiction (naltrexone, acamprosate,
and disulﬁram). Barriers to eﬀective
MAT use include limited treatment
locations due to licensing restrictions
and limited prescribers, lack of
availability of medications in
pharmacies, and stigma associated
with opioid use and treatment
(e.g., 12-step programs that require
drug abstinence and attitudes that
substance addiction is a character
ﬂaw rather than a chronic disease
requiring a long-term treatment
approach with MAT as a necessary
component). Dipaula advises patients
to establish routine care with a
knowledgeable medical team that
tailors care to each individual and
treats the whole person rather than
each disease or condition in isolation.
MAT prescriptions should ideally be
ﬁlled at the same pharmacy.
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Physician’s perspective
Anika Alvanzo, MD, Assistant
Professor in the Division of General
Internal Medicine at Johns Hopkins
University School of Medicine,
described the mission of the SUD
consultation service she directs at
Johns Hopkins Hospital as improving
the health and quality of life of
patients with SUD by providing
non-judgmental, comprehensive
and patient-centered care and
education. Each patient’s plan of
care is informed by an assessment
that uses a motivational interviewing
framework based on DiClemente’s
Stages of Change model. She points
to stigmatizing language often
used to refer to persons with SUD
(e.g., referring to them as “addicts,”
“alcoholics,” “drug abusers,” “clean,”
or having “relapsed”). Health care
professionals often see a biased
sample of persons with severe SUD
so become pessimistic about recovery
potential, which impairs their ability
to develop rapport. They underappreciate how awful it feels to
withdraw from substance use (what
some have described as the “worst ﬂu
you’ve had, times 10”), and dismiss
legitimate pain as “drug seeking.”
Dr. Alvanzo looks for “teachable
moments” where she can enlighten
staﬀ about what eﬀective SUD
interventions look like and how they
can transform lives.
Social worker’s perspective
Michelle Tuten, MSW, PhD,
Assistant Professor at the University
of Maryland, Baltimore, School of
Social Work and Adjunct Assistant
Professor at Johns Hopkins
University School of Medicine,
has 20 years of experience in the
treatment of SUDs through her work
as a clinician and SUD treatment
program director. One particular issue
she has explored is what happens
to women with a SUD who become
pregnant. Society reserves harsh

judgment for such women, despite
pregnancy not being a cure for SUD.
While there is already a concern
about insuﬃcient availability of
SUD treatment programs and poor
insurance coverage, this is even more
pronounced when searching for SUD
recovery programs equipped to treat
a mom and fetus/newborn dyad.
Moreover, these women are often
shamed and threatened with criminal
prosecution (in some states), so they
delay seeking treatment, fearing they
may lose their parental rights if their
SUD is discovered. The conﬂicting
duties to treat the mom’s chronic
relapsing disorder while also looking
out for the best interests of the child
presents an ethical dilemma. Yet,
treating the mom with compassion
and competent care rather than blame
and judgment is more likely to beneﬁt
both her and her child.
Health lawyer’s perspective
Richard Boldt, JD, faculty
member at the University of
Maryland Francis King Carey School
of Law, has researched drug policy
and the legal issues surrounding
drug use disorders. He believes
that reliance on the criminal justice
system as a way of addressing drug
addiction is ethically ﬂawed. For
example, the President’s Commission
on the opioid crisis recently
recommended use of drug courts,
where teams of lawyers, judges, case
managers, social workers, and other
SUD treatment specialists work to
meet the needs of individuals with
SUD who enter into the criminal
justice system. The thinking is that
SUD recovery aims can be furthered
by leveraging the coercive authority
of the court. However, treatmentpunishment hybrids often become
debased; the punishment ultimately
overrides the treatment component.
Racial minorities and lower risk
oﬀenders are disproportionately
targeted, mental health services

oﬀered are substandard (sometimes
drug courts disallow medicationassisted treatment), and those
who “fail” end up with longer
sentences. Instead, policy makers
should prioritize community-based
addictions treatment programs that
are accessed upstream, rather than
diverting individuals to treatment
after they enter the criminal justice
system. One promising model is
when law enforcement provides “safe
spaces” for drug-addicted persons,
or Seattle’s program where police
oﬃcers divert those with substance
addictions to community programs.
Decriminalizing drug addiction
and funding its treatment as a
chronic disease is supported both by
public health outcomes and ethical
standards.
Perspective from an addictions
nurse
Katherine Fornili, DNP, Assistant
Professor at the University of
Maryland School of Nursing and
President-Elect of the International
Nurses Society on Addictions, shared
sobering statistics about the opioid
crisis and its roots. For example,
despite the death toll from opioid
overdose topping 52,000 in 2015,
only one in ten people who suﬀer
from SUD receive any type of
treatment. Various federal initiatives
are being implemented to prevent
drug use, promote early intervention,
and integrate treatment for SUD
across healthcare disciplines. The
Department of Health and Human
Services has identiﬁed three
priority areas: (1) improved opioid
prescribing practices, (2) expanded
distribution and use of naloxone to
reverse eﬀects of opioids and prevent
overdose fatalities, and (3) expansion
of medication-assisted treatment
options. Unfortunately, politics,
ignorance, and bias have thwarted
eﬀorts to properly fund and prioritize
interventions that would reduce
SUD prevalence and improve access

to recovery and harm reduction
programs (e.g., needle exchange, test
kits to allow persons to verify what
drugs they are using, and access to
safe injection sites). Since addiction
is a chronic illness characterized
by alternating periods of substance
use and abstinence, a plan must be
devised to anticipate this trajectory.
Attention to the social determinants
of health is paramount. Unfortunately,
gains made under the Aﬀordable
Care Act (e.g., health coverage for
mental health services, limits on outof-pocket spending, and expanded
prescription drug coverage) may
be lost given the current budgetary
and political climate. Bills recently
passed (the Drug Addiction Treatment
Act, the Recovery Enhancement for
Addiction Treatment Act of 2015-16,
and the Comprehensive Addiction
Treatment Act of 2016) did not
come with funding. The Substance
Abuse and Mental Health Services
Administration’s website (https://
www.samhsa.gov/) is a good starting
point for those looking for SUD
resources. But clearly, more advocacy
work is needed to create policies
and foster attitudes that help those
in active addiction and at risk for
addiction to get the help they need
and deserve.
NOTES
1. Hilgers, L. (2017, November
4). Let’s Open Up about Addiction
& Recovery. The New York Times.
Retrieved from: https://www.nytimes.
com/2017/11/04/opinion/sunday/
drug-addiction-recovery-alcoholism.
html
2. See The American Journal
of Bioethics January 2018 issue
(Volume 18, Issue 1) for the case and
related ethical commentaries.

NEW BOOK:
Courageous Conversations
by Shahid Aziz, M.D.
If you search on Amazon
for topics related to death and
dying, you will retrieve over
20,000 titles. If you are looking
to hone that search, here is a
new title to explore: Courageous
Conversations on Dying - The Gift
of Palliative Care: A Practical
Guide for Physicians, Healthcare
Providers, & All the People They
Serve by Shahid Aziz, M.D. Dr.
Aziz is a long-time friend and
supporter of MHECN as well
as former chair of MHECN’s
Education Committee. In his work
as a pediatrician and as Harbor
Hospital’s ethics committee chair,
he became intimately familiar with
the shortcomings of how clinicians
communicate about death and
dying with patients and families.
These communication missteps
and missed opportunities have
fueled a majority of the ethics
consultation requests that ethics
committees receive. This inspired
Dr. Aziz to switch his professional
focus and obtain board-certiﬁcation
in hospice and palliative care
medicine. He now concentrates
in palliative and end-of-life care.
Dr. Aziz developed a particular
approach to advance care planning
that moves away from a checklist
approach toward a goals-of-care
approach. After teaching this
approach in workshop format
to hundreds of individuals, he
now shares it more broadly in his
book. Courageous Conversations
walks the reader through the
steps of eﬀective advance care
planning conversations and how
to document these, and contains
numerous helpful insights, tips,
and case studies. While end-of-life
care experts are needed, all health
care providers must play a role in
facilitating advance care planning.
Dr. Aziz’s book is a roadmap for
how to get there.
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CASE PRESENTATION
One of the regular features of this Newsletter is the presentation of a case considered in an ethics committee and an analysis
of the ethical issues involved. Readers are both encouraged to comment on the case or analysis and to submit other cases that
their ethics committee has dealth with. In all cases, identifying information about patients and others in the case should only be
provided with the permission of the patient. Unless otherwise indicated, our policy is not to identify the submitter or institution.
We may also change facts to protect conﬁdentiality. Cases and comments should be sent to MHECN@law.umaryland.edu.

CASE STUDY - PARENTAL REFUSAL OF LIFE-SUSTAINING INTERVENTIONS IN A NEWBORN

Boy L was born full term to a married Nigerian couple visiting family in the U.S. The baby’s mother did not have any pre-natal
exams so she and the delivery team did not know that the baby had Down syndrome. The baby required some respiratory support
at delivery warranting a NICU admission. The clinicians noted a cleft palate and suspected other congenital anomalies such
as duodenal atresia. Before the NICU team could ﬁnish the complete diagnostic work-up, the parents requested that no further
testing be performed. They explained that in their country, a child with these conditions has no meaningful chance of a good
quality of life. They requested that the child not be given any further medical treatments, including intravenous nutrition and
hydration, and that the infant be allowed to die. The NICU team wondered whether this would constitute medical neglect. They
consult the ethics committee for guidance.
COMMENTS FROM A NICU NURSE, NEONATOLOGIST, AND NEONATAL NURSE PRACTITIONERS
As the nascent ﬁeld of Neonatology has evolved, so have opinions and policies regarding the medical, legal, and ethical
care of newborn infants, especially those born with congenital anomalies and genetic syndromes such as Trisomy 21. As
evidenced by widely publicized cases at Johns Hopkins and Yale in the 1960s and 1970s, it was “ethically acceptable”
to forego surgical interventions for such infants, and allow natural death to occur. These decisions were paternalistic in
nature, and largely based on the belief that the parents’ future burden in taking care of an infant with complex medical
issues was paramount. The “right to die” as well as a parental right to choose for their infant (parental authority) were the
dominant ethical principles.
The 1980s saw a signiﬁcant paradigm shift toward “life-at-all-costs,” which began following public awareness of the
Baby Doe case. Baby Doe was born in 1982 in Indiana, and was diagnosed with Trisomy 21 and tracheoesophageal
ﬁstula. The obstetrician informed the family that developmental outcomes were dismal for children with Trisomy 21, and
counseled the family to withhold surgical intervention. Other physicians disagreed, and petitioned the court. The Indiana
State Supreme Court ruled that the child’s parents had a right to choose the baby’s treatment and the infant died without
surgery. This case galvanized right-to-life advocates within the Reagan Administration to pass the “Baby Doe Laws,”
to ensure that all infants received life-sustaining interventions, regardless of diagnosis. This eﬀectively removed the
consideration of “quality of life,” and minimized parental authority.
Over the past 35 years, the pendulum has swung back toward an ethical middle ground. Shared Decision Making
(SDM) between parents and the health care team is emphasized and endorsed by The American Academy of Pediatrics
(AAP). In the SDM model, parental authority is prioritized and respected, with guidance based upon the experience and
expertise of the medical team. In 2017, the AAP Committee on Bioethics published a policy statement titled, “Guidance
on Forgoing Life-sustaining Treatment.” This policy statement emphasizes both parental authority and promoting the
best interest of the child (“best interest standard”), with eﬀorts aimed toward interventions that sustain life. Collaborative
communication and SDM between healthcare providers and families regarding the beneﬁts and burdens across a range of
treatment options is vital to these ethically-based decisions.
In Trisomy 21, there is an extra copy of chromosome 21, increasing the total number of chromosomes from 46 to 47.
This extra copy of chromosome 21 is responsible for development of congenital anomalies, including characteristic facial
features and cognitive impairment. The spectrum of congenital anomalies often includes hearing loss, congenital heart
disease, and gastrointestinal (GI) malformations such as duodenal atresia. Although a wide range in degree of cognitive
impairment occurs, severe impairment is less common and quality of life for children with Trisomy 21 is generally
achievable. Thus, surgical interventions that sustain life are thought to be in the best interest of the child. While in the
1970s fewer than 50% of physicians recommended surgical interventions for Trisomy 21, it is now considered standard
of care.
Would withholding surgery in this infant be considered medical neglect? Medical neglect occurs when parents fail
to provide adequate treatment for their child, possibly resulting in harm or death. In this case, parents declined further
diagnostic testing or treatment of known medical conditions, which could be considered medical neglect. The cleft palate
may hinder feeding and optimal language development, and requires surgical repair. Duodenal atresia requires surgical
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intervention to sustain life. In the United States, the morbidity and mortality associated with this procedure are negligible,
and the beneﬁts of surgery outweigh the risks. Thus, both surgeries would be oﬀered to infants with Trisomy 21,
especially in the absence of life-limiting comorbidities. In fact, surgical repair of more severe cardiac malformations
and treatment of conditions such as leukemia associated with Trisomy 21 are routinely oﬀered based on modern ethical
opinions of the quality of life associated with this condition. Quality of life, however, is highly subjective, especially in
the case of infants who cannot speak for themselves, and therefore parents are traditionally seen as the best advocates for
their child. Cultural inﬂuences, religious beliefs, personal experiences, and biases drive parents’ perspectives of quality
of life. When caring for infants with life-limiting diagnoses, focusing on goals of care can help lend understanding of
parents’ desires for their infant and their deﬁnition of quality of life.
In this case, the parents have expressed a desire that the child be allowed to die, which in their opinion is in the infant’s
best interest. Thus, there is conﬂict between the parents’ and the medical team’s guiding principle of right to life and
their deﬁnition of quality of life for infants with Trisomy 21. This case is further complicated by the fact that the parents
are planning to return to Nigeria. Several questions then arise: 1) What information was provided to the parents by the
medical team regarding prognosis and natural history of Trisomy 21? 2) What is preventing a good quality of life for this
child in Nigeria (for example, resources, social stigma) and can those conditions be altered? 3) Should the medical team
seek assistance from the legal system in order to determine next steps, complete diagnostic testing and perform surgeries
without parental consent? 4) Would the infant be subsequently placed in the U.S. foster care system or would the parents
be allowed to resume custody and return to Nigeria? 5) Should custody be taken from the parents, and the “best interest
standard” followed, to meet the U.S. medical system’s deﬁnition of quality of life for children with Trisomy 21 and
ultimately preserve life? Right to life and quality of life, as perceived by the medical team, would be obtained at a price.
This includes loss of parental authority and sacriﬁce of parents’ right to raise their child within their value system. These
concepts require further examination and exploration prior to any decisions regarding the outcome of this case.
Respect for autonomy dictates that the choices of the patient with decision-making capacity be honored. Parental
authority is a similar but unique concept. As surrogate decision makers, parents are expected to make decisions that are
in the best interest of their child. In certain conditions, it may be permissible and even obligatory to override parental
decisions based on the best interest standard.
Similar sentiments are echoed within the Constitution of the Federal Republic of Nigeria. Civil and criminal laws aim
to preserve the right to life. According to the Nigerian Child Rights Act, ethical decision making should focus on the
best interest of the child; every child has the right to protection of his/her well-being, and the right to health and health
service. In extreme cases, however, it is acceptable to withhold or withdraw treatment.
In this diﬃcult case, it is likely that the medical team would feel obligated to treat. However, medical providers should
make every eﬀort to respect parental authority, and remain sensitive to cultural values and the belief of the patient’s
family. Continued eﬀorts aimed at collaborative and transparent communication may aid in mutual understanding and
lead to development of an acceptable treatment plan.
Lucy Rose Davidoﬀ RN, Dawn Mueller-Burke PhD, NNP-BC, Nikki Brandon MS, NNP-BC, Alison J. Falck MD,
Division of Neonatology & Neonatal Intensive Care Unit, University of Maryland Medical Center
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COMMENTS FROM CLINICAL
ETHICS CONSULTANTS
In the case of Baby Boy L, there is
a range of intersecting interests and
obligations implicated including: 1)
the interests of the patient himself;
2) the interests of his parents as
his parents; and 3) the correlated
obligations of the medical team and
our society in protecting the interests
of individuals who cannot protect
themselves, especially children, and
speciﬁcally children with disabilities.
Based on these interests, we describe
and rank the ethical acceptability of
various potential resolutions for the
dilemma this case presents.
The ethical issue
The morally laden choice facing
the care team is whether to honor the
parents' request and allow the patient
to die, or to overrule the parents'
wishes and save the patient’s life. The
ethical dilemma is whether to aﬃrm
the parents' interests as parents while
respecting their construction of their
child’s future interests, and letting the
patient die, or to overrule the parents'
choice and substitute our society’s
construction of the child’s interests,
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and subsequently act to save the
child’s life.
Reasons to honor the parents'
request
The care team ought to consider
honoring the parents’ request out
of respect for their autonomy and
inherent right to care for their son as
they believe to be best. Parents have
an interest and a correlated societal
right to care for their children without
unnecessary interference from others.
Hospitals have an obligation to
respect the autonomy and dignity of
parents as caregivers and guardians
for their children. The societal
boundaries of the parental right to
raise children as the parent sees ﬁt
end where abuse and neglect begin.
Absent clear showings of harm,
it’s unethical and inappropriate to
substitute the community’s judgment
for a parent’s choices in matters
regarding childrearing.
In our society we tolerate
potentially suboptimal parenting
behavior due to a commitment
to respecting parental rights
and autonomy. This is ethically

appropriate for several reasons. First,
people should be able to construct
their personal relationships and
families consistent with their own
cultural norms and values. Second, in
most cases, the people that are best
positioned to maintain and promote
a child’s best interests are his or her
parents. The default societal position
that parents have an inherent right
to raise their children as they see
best should only be overturned in
extenuating circumstances where
clear harms can be demonstrated.
The question here is where to draw
the line in deﬁning these extenuating
circumstances.
Reasons to overrule the parents’
wishes and operate on the patient
There are two arguments for
overruling the parents’ wishes
and saving the patient’s life. First,
children have an interest in their own
health, and the opportunity to live
out their future interests as their own
person. Death extinguishes those
interests.
Second, communities have an
interest and a correlated obligation
and authority to protect and promote

the interests of individuals who
cannot act on their own behalf.
This is especially true for children
and individuals who have certain
impairments and disabilities, or
who are a member of a historically
disadvantaged class. This interest
and obligation is reﬂected in child
protection and disability rights law.
The Baby Doe Rules are an example
of an explicit policy designed to
protect the interests of children like
Baby L. Whether or not the Baby
Doe Rules apply in this case is
unclear; however, the rules create an
obligation on healthcare providers
to intervene and care for a child
in circumstances where a child’s
welfare would be harmed on the basis
of an inappropriate discrimination
against a disabled child. If Baby
L’s parents are making the decision
to allow him to die of an otherwise
survivable condition on the basis of
discrimination against children with
Down syndrome, then it would be
ethically appropriate and consistent
with regulatory requirements to
intervene and save the patient’s life.
Possible Resolutions
There is a range of potential
resolutions to this ethical dilemma
that vary in their practicability and
ethical acceptability.
We suggest that the best option
would be to save the patient’s life
while preserving the integrity of the
family. An ideal variation of this
option might involve supporting the
family if they desire and are able
to stay in the U.S.. However, this
presents a challenge if the parents
must return to Nigeria, given the
pervasive negative attitudes there
toward persons with disabilities, and
few aﬀordable resources to allow
Baby L to thrive. Although Baby
L’s life is preserved and his family
remains intact, his life in Nigeria
will probably involve challenges

that reduce his quality of life. This
case epitomizes the weight of moral
residue accompanying ethical
dilemmas involving both cultural
relativism and inequality in the
distribution of wealth and resources
across the world.
Thus, the next best option may be
to explore adoption with the parents.
If they consented to the surgical
intervention to allow the baby to feed
and grow, they could then agree to
place the child up for adoption if they
decide they do not want to parent
the child. This aﬃrms the patient’s
interests, and is consistent with the
parents’ interests to the extent their
choices are voluntary. This solution is
practicable, but also depends on the
child being adopted by a caring and
supportive family.
Two other options remain; however,
these result in harms to persons that
are ethically problematic.
The ﬁrst of these is to obtain a
court ruling to proceed with surgical
intervention to save the baby’s life,
along with involuntary termination of
the parents’ rights and placement of
the child in the foster care system for
adoption. This aﬃrms the patient’s
interests in life, but harms the parents’
interests as parents of the patient.
The ﬁnal option is to honor the
parents’ wishes and allow the patient
to die; however, this harms the
patient’s interests in a future life.
This also potentially undermines
the societal institutions and norms
for the protection of children with
disabilities.
Culture and contextual
considerations
Given the patient and family’s
national and cultural background,
it is important to consider the
historical context for the involuntary
termination of the parental rights of
persons who are not members of the
dominant culture in our society. In

this case, the option of involuntarily
terminating parental rights implicates
additional concern regarding racial
inequities in power and privilege in
the U.S. Historically, the substitution
of a societal construction of a child’s
interests as a basis to involuntarily
terminate parental rights has occurred
at disproportionately higher rates in
minority families. This includes a
history of systematically terminating
the parental rights of Native
American/American Indian families,
and an ongoing discrepancy in the
rates of terminations of parental
rights in minority families. Although
it may be ethically appropriate in
the individual case, it’s important
to consider that this choice may be
embedded in a broader history of
supremacy where a dominant culture
invalidates the parental interests of
minority parents under a justiﬁcation
that the dominant culture’s values
have greater weight or validity.
Conclusion
An ethical resolution of this
case ought to take into account
the interests and obligations of all
stakeholders. It is essential that the
analysis extend beyond the narrow
question of whether the withholding
of treatment constitutes medical
neglect.
Additional considerations should
include the parents’ interests as
parents, the patient’s future interests
in health and quality of life, and
our society’s interest in protecting
vulnerable individuals. The relative
importance of these considerations
remains debatable; our society’s
values and commitments regarding
the government’s role in protecting
children and intervening in private
family aﬀairs will vary and
continuously evolve. We suggest that
the best option would be to save the
patient’s life while preserving the
integrity of his family.
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We would also maintain that there is
an ethical obligation to systematically
pursue the best options ﬁrst, and
proceed through the next best option,
before considering options resulting
in ethically problematic harms.
Joel T. Wu, JD, MPH, MA
Clinical Ethics Fellow
Clinical Ethics Department
Children's Hospitals and Clinics
of Minnesota
Nneka O. Sederstrom, PhD,
MPH, MA, FCCP, FCCM
Director
Clinical Ethics Department
Children's Hospitals and Clinics
of Minnesota

In Memoriam: Bob Roby, M.D.

March 15th marked the one-year anniversary of the death of Dr. Robert (“Bob”) Roby, geriatrician and devoted
advocate of services for the elderly. Dr. Roby graduated from University of Maryland Medical School and completed
Postgraduate Medical Training in internal medicine at Maryland General Hospital (now University of Maryland Medical
Center Midtown Campus – UMMC Midtown). He was Chief of the Emergency Department at Maryland General for
over 25 years. From 2004 until his death, Dr. Roby served as Coordinating Physician for Geriatric Physician Services
at UMMC Midtown. He joined that hospital’s ethics committee in 1994 and MHECN’s Education committee in 2001.
Dr. Roby was also active in geriatric and nursing home and assisted living medicine from 1979 until his death in 2017.
He served as medical director at multiple Baltimore area nursing homes over many years. Dr. Roby also held leadership
positions, including serving on the Executive Council for the National Nursing Home System’s National Medical Director
Advisory Board. In 2008, he was nominated for National Medical Director of the Year by the American Medical Directors
Association (now called AMDA – The Society for Post-Acute and Long-Term Care Medicine). His extensive experience
and encyclopedic knowledge of emergency medicine and long-term care made him a tireless advocate for improving
patient care. His co-workers, students, and mentees recognized him as a true leader and role model. One year after his
death, his dynamic presence and ethics advocacy is still missed.
14 Mid-Atlantic Ethics Committee Newsletter

CALENDAR OF EVENTS
Spring 2018
MAY
10-11
Brain-based and Artiﬁcial Intelligence: Socio-ethical Conversations in Computing and Neurotechnology,
Organized by the Center for the Study of Ethics in the Professions, Illinois Institute of Technology, Chicago,
IL. Visit: http://ethics.iit.edu/BrainAIWorkshop
JUNE
4-7
Foundations of Bioethics, sponsored by The Interdisciplinary Center for Bioethics at Yale University, New
Haven, CT. Visit: bioethics.yale.edu/summer. (Longer program also available June 1-July 21.)
4-14
Summer Institute in Bioethics, sponsored by the Johns Hopkins Berman Institute of Bioethics. Visit: http://
www.bioethicsinstitute.org/summer-institute
• PH.700.600 Basics of Bioethics (2 credits)
• PH.700.702 The Ethics of Making Babies (2 credits)
• PH.221.656.11 Conceptual and Evidential Foundations of Health Equity and Social Justice (4 credits)
8-11
Clinical Ethics Immersion, sponsored by the Center for Ethics at MedStar Washington Hospital Center,
Washington, DC. Visit: https://www.medstarwashington.org/our-hospital/center-for-ethics/clinical-ethicsimmersion/#q={}
13 (8am-12pm)
Practical Clinical Ethics: Addressing the Suﬀering of Mind, Body and Spirit, sponsored by Harbor Hospital's
Ethics Committee, Harbor Hospital, Baltimore MD. MHECN members can register at a reduced rate
(MedStar Harbor Associates' rate). Visit http://www.law.umaryland.edu/MHECN and click on "Conferences"
for registration information.
21-23
The 14th Annual International Conference on Clinical Ethics & Consultation (ICCEC), hosted by the Institute
of Medical Ethics, Oxford, UK. Visit: iccec2018.org
Bioethics and Being Human, sponsored by The Center for Bioethics & Human Dignity, Deerﬁeld, IL. Visit:
https://cbhd.org/conf2018

RECURRING EVENTS
Johns Hopkins Berman Institute of Bioethics Seminar Series, either at Sheik Zayed Tower Chevy Chase
Conference Center (1800 Orleans St.) or Feinstone Hall, E2030, Bloomberg School of Public Health (615
N. Wolfe St.) Baltimore, MD. 12N-1:15PM. Visit: http://www.bioethicsinstitute.org/educationtraining-2/
seminar-series
May 14 speaker: Understanding the potential of state-based public health genomics programs to mitigate
disparities in access to clinical genetic services, Laura Senier, PhD, MPH (Zayed)
May 21 speaker: Risk and beneﬁt for pediatric Phase I trails in oncology: a meta-analysis and ethical
implications, Marcin Waligora, PhD (Deering Hall, Lower Level)
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The Law & Health Care Program
Maryland Health Care Ethics
Committee Network
University of Maryland
Francis King Carey School of Law
500 W. Baltimore Street
Baltimore, MD 21201

The Maryland Healthcare Ethics Committee Network (MHECN) is a membership organization, established by the Law and
Health Care Program at the University of Maryland Francis King Carey School of Law. The purpose of MHECN is to facilitate
and enhance ethical reﬂection in all aspects of decision making in health care settings by supporting and providing informational
and educational resources to ethics committees serving health care institutions in the state of Maryland. The Network attempts to
achieve this goal by:
•

Serving as a resource to ethics committees as they investigate ethical dilemmas within their institution and as they strive to
assist their institution act consistently with its mission statement;

•

Fostering communication and information sharing among Network members;

•

Providing educational programs for ethics committee members, other healthcare providers, and members of the general
public on ethical issues in health care; and

•

Conducting research to improve the functioning of ethics committees and ultimately the care of patients in Maryland.

MHECN appreciates the support of its individual and institutional members. MHECN also welcomes support from aﬃliate
members who provide additional ﬁnancial support.
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